| Literature DB >> 10960308 |
Abstract
Monsanto Co. has agreed to provide royalty-free licenses to speed up work on a genetically modified rice that could alleviate vitamin A deficiency around the world. Researchers welcomed last week's announcement, but warn that a thicket of intellectual property claims surrounds the technology and that significant legal hurdles remain before the rice can become widely available to farmers in developing countries.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10960308 DOI: 10.1126/science.289.5481.843
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728